Anti-TNR16/ NGFR/ CD271 monoclonal antibody

Anti-TNR16/ NGFR/ CD271 antibody for FACS & in-vivo assay

Target products collectionGo to NGFR/NGFR products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T50942-Ab-1/ GM-Tg-hg-T50942-Ab-2Anti-Human NGFR monoclonal antibodyHuman
GM-Tg-rg-T50942-Ab-1/ GM-Tg-rg-T50942-Ab-2Anti-Rat NGFR monoclonal antibodyRat
GM-Tg-mg-T50942-Ab-1/ GM-Tg-mg-T50942-Ab-2Anti-Mouse NGFR monoclonal antibodyMouse
GM-Tg-cynog-T50942-Ab-1/ GM-Tg-cynog-T50942-Ab-2Anti-Cynomolgus/ Rhesus macaque NGFR monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T50942-Ab-1/ GM-Tg-felg-T50942-Ab-2Anti-Feline NGFR monoclonal antibodyFeline
GM-Tg-cang-T50942-Ab-1/ GM-Tg-cang-T50942-Ab-2Anti-Canine NGFR monoclonal antibodyCanine
GM-Tg-bovg-T50942-Ab-1/ GM-Tg-bovg-T50942-Ab-2Anti-Bovine NGFR monoclonal antibodyBovine
GM-Tg-equg-T50942-Ab-1/ GM-Tg-equg-T50942-Ab-2Anti-Equine NGFR monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T50942-Ab-1/ GM-Tg-hg-T50942-Ab-2; GM-Tg-rg-T50942-Ab-1/ GM-Tg-rg-T50942-Ab-2;
GM-Tg-mg-T50942-Ab-1/ GM-Tg-mg-T50942-Ab-2; GM-Tg-cynog-T50942-Ab-1/ GM-Tg-cynog-T50942-Ab-2;
GM-Tg-felg-T50942-Ab-1/ GM-Tg-felg-T50942-Ab-2; GM-Tg-cang-T50942-Ab-1/ GM-Tg-cang-T50942-Ab-2;
GM-Tg-bovg-T50942-Ab-1/ GM-Tg-bovg-T50942-Ab-2; GM-Tg-equg-T50942-Ab-1/ GM-Tg-equg-T50942-Ab-2
Products NameAnti-NGFR monoclonal antibody
Formatmab
Target NameNGFR
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-NGFR benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species TNR16/ NGFR/ CD271 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLP003686human NGFR Lentivirus plasmid
    ORF Viral VectorvGMLP003686human NGFR Lentivirus particle
    ORF Viral VectorpGMAAV000213house mouse Ngfr AAV plasmid
    ORF Viral VectorpGMLPm002516mouse Ngfr Lentivirus plasmid
    ORF Viral VectorvGMAAV000213house mouse Ngfr AAV particle
    ORF Viral VectorvGMLPm002516mouse Ngfr Lentivirus particle


    Target information

    Target IDGM-T50942
    Target NameNGFR
    Gene ID4804,18053,24596,574304,491071,101101519,353110,100069694
    Gene Symbol and SynonymsCD271,Gp80-LNGFR,LNGFR,NGFR,p75,p75(NTR),p75NGFR,p75NTR,RNNGFRR,TNFRSF16
    Uniprot AccessionP08138,P07174
    Uniprot Entry NameTNR16_HUMAN,TNR16_RAT
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target
    DiseaseCancer
    Gene EnsemblENSG00000064300
    Target ClassificationTumor-associated antigen (TAA)

    The target: NGFR, gene name: NGFR, also named as CD271, Gp80-LNGFR, TNFRSF16, p75(NTR), p75NTR. Nerve growth factor receptor contains an extracellular domain containing four 40-amino acid repeats with 6 cysteine residues at conserved positions followed by a serine/threonine-rich region, a single transmembrane domain, and a 155-amino acid cytoplasmic domain. The cysteine-rich region contains the nerve growth factor binding domain. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.